Antimicrobial use and stewardship opportunities in Burkina Faso: findings from the first Global Point Prevalence Survey in eight hospitals
Authors:
Open Access
- 5 February 2026
- journal article
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1)
Abstract
Objective: To describe the prevalence, patterns, and quality indicators of antimicrobial use (AMU) in Burkinabe hospitals and identify priorities for stewardship. Design: Multicentre, cross-sectional point prevalence survey (PPS) following the Global Point Prevalence Survey protocol. Setting: Eight public hospitals across six cities in Burkina Faso (3 primary, 3 secondary, and 2 tertiary), February–June 2019. Participants: All inpatients present on the survey day at 8:00. Medical records were reviewed for those receiving systemic antimicrobial agents. Methods: Standardized ward- and patient-level data were collected on indications, agents, routes, and WHO AWaRe categories, alongside quality indicators (documented indication, stop/review date, guideline compliance, and targeted vs empirical therapy). Descriptive analyses compared hospital tiers. Results: Of 994 inpatients, 729 (73.3%) received ≥1 antimicrobial (range by tier: tertiary 69.7%, secondary 79.2%, primary 79.2%). Community-acquired infections accounted for 96.0% of therapeutic indications. Leading reasons were skin/soft tissue infections (12.2%), gastrointestinal infections (10.7%), and pneumonia (10.4%). Parenteral administration predominated. The most used agents were ceftriaxone (27.8%), metronidazole (15.7%), and gentamicin (9.4%). By AWaRe, Access agents comprised ∼ 50%, Watch agents ∼ 50% overall, with higher Watch use in tertiary hospitals; no Reserve antibiotics were recorded. Quality indicators were suboptimal: the indication was documented in 15.6%, the stop/review date was absent in 93.0%, and 41.1% of prescriptions were guideline-compliant. Therapy was largely empirical (98.5%). Prolonged surgical prophylaxis (>1 day) represented 86.8% of prophylaxis courses. Conclusions: Antimicrobial use (AMU) prevalence in Burkinabe hospitals is high, dominated by empirical therapy and Watch-class ceftriaxone. Deficits in prescribing quality and limited diagnostic use highlight urgent needs for context-adapted antimicrobial stewardship: enforce guideline-concordant care, curb prolonged prophylaxis and unnecessary Watch-class use, and expand affordable microbiology capacity to enable targeted therapy.Keywords
This publication has 18 references indexed in Scilit:
- 36-fold higher estimate of deaths attributable to red meat intake in GBD 2019: is this reliable? – Author's replyThe Lancet, 2022
- Assessing the impact of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) on hospital antimicrobial stewardship programmes: results of a worldwide surveyAntimicrobial Resistance & Infection Control, 2021
- Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countriesJournal of Antimicrobial Chemotherapy, 2021
- A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in IndiaJournal of Antimicrobial Chemotherapy, 2021
- Revue de la politique et du cadre réglementaire de l’optimisation de la gestion des antimicrobiens au Burkina FasoPAMJ - One Health, 2021
- Global point prevalence survey of antimicrobial consumption in Brazilian hospitalsJournal of Hospital Infection, 2020
- Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence surveyThe Lancet Global Health, 2018
- Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infectionsAmerican Journal of Health-System Pharmacy, 2014
- Appropriateness of Antimicrobial Therapy Measured by Repeated Prevalence SurveysAntimicrobial Agents and Chemotherapy, 2007
- The use of serial point-prevalence studies to investigate hospital anti-infective prescribingInternational Journal of Pharmacy Practice, 2002